Agilent Technologies, Inc. (NYSE:A) Given Consensus Rating of "Moderate Buy" by Analysts

FierceBiotechMcKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B

FierceBiotechAcuityMD raises $80M to help bolster AI in the medtech industry

FierceBiotechAACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’

FierceBiotechMerck goes with Google for AI push, striking enterprise partnership worth up to $1B

Thermo FisherGlobal Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation - PR Newswire

AgilentAgilent’s Expanding Role in Advanced Therapeutics - Contract Pharma

BioWorldAI opens the way to systematic risk assessment of zoonotic potential of viruses

BioWorldSingularity Pharma discloses new mitragynine analogues

BioWorldJiangsu Vcare Pharmatech identifies new IL-17A inhibitors

BioWorldRuijin Hospital and Shanghai Jiao Tong University discover GSPT1 degradation inducers

AgilentAgilent Technologies (A) Launches Key Cancer Diagnostic Tool - GuruFocus

FierceBiotechNovartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial